Healios K.K
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ische… Read more
Market Cap & Net Worth: Healios K.K (HLOSF)
Healios K.K (PINK:HLOSF) has a market capitalization of $224.51 Million ($224.51 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #17595 globally and #6655 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Healios K.K's stock price $1.94 by its total outstanding shares 115726901 (115.73 Million).
Healios K.K Market Cap History: 2020 to 2025
Healios K.K's market capitalization history from 2020 to 2025. Data shows change from $2.07 Billion to $224.51 Million (-40.08% CAGR).
Healios K.K Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Healios K.K's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.16x
Healios K.K's market cap is 2.16 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.07 Billion | $27.00 Million | -$5.51 Billion | 76.51x | N/A |
| 2021 | $1.68 Billion | $41.00 Million | -$4.91 Billion | 41.07x | N/A |
| 2022 | $1.68 Billion | $90.00 Million | -$5.17 Billion | 18.71x | N/A |
| 2023 | $1.68 Billion | $121.00 Million | -$3.82 Billion | 13.92x | N/A |
| 2024 | $138.87 Million | $560.00 Million | -$4.24 Billion | 0.25x | N/A |
| 2025 | $224.51 Million | $104.09 Million | -$2.22 Billion | 2.16x | N/A |
Competitor Companies of HLOSF by Market Capitalization
Companies near Healios K.K in the global market cap rankings as of March 18, 2026.
Key companies related to Healios K.K by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Healios K.K Historical Marketcap From 2020 to 2025
Between 2020 and today, Healios K.K's market cap moved from $2.07 Billion to $ 224.51 Million, with a yearly change of -40.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $224.51 Million | +61.67% |
| 2024 | $138.87 Million | -91.75% |
| 2023 | $1.68 Billion | 0.00% |
| 2022 | $1.68 Billion | 0.00% |
| 2021 | $1.68 Billion | -18.49% |
| 2020 | $2.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Healios K.K was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $224.51 Million USD |
| MoneyControl | $224.51 Million USD |
| MarketWatch | $224.51 Million USD |
| marketcap.company | $224.51 Million USD |
| Reuters | $224.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.